To confirm that PRP promotes the osteogenic differentiation of hADSCs at the molecular level and to explore the mechanism of action of hsa-miR-212-5p and CNR1, we detected the expression of hsa-miR-212-5p and CNR1 in the OM and PRP groups on day 14 and detected the expression of the ALP, Runx2, OCN, and COL1A1 osteogenic markers. The gene discussed is BGLAP; the disease is ocular melanoma.